Lithium - past, present, future

Int J Psychiatry Clin Pract. 2020 Nov;24(4):330-340. doi: 10.1080/13651501.2020.1775855. Epub 2020 Jun 17.

Abstract

Objectives: A narrative review of past, present, and future of lithium use in psychiatry.

Methods: The most important references on the topic were reviewed with special emphasis on the author's works.

Results: The history of medical and psychiatric use of lithium dates back to more than one and a half-century ago. However, modern psychiatric history began with the publication of John Cade, in 1949, showing a therapeutic effect of lithium in mania. Currently, lithium is a drug of choice as a mood-stabilizer for the maintenance treatment of the bipolar disorder. The second most important use of lithium is probably augmentation of antidepressants in treatment-resistant depression. In addition to its mood-stabilizing properties, lithium exerts anti-suicidal, immunomodulatory, and neuroprotective action. The drug may protect against dementia and some promising effects of lithium in neurodegenerative disorders have been observed.

Conclusion: Given the clinical and biological properties of lithium, this drug is presently greatly underutilized in mood disorders. Therefore, the efforts should be undertaken for challenging a skepticism about the use of lithium and optimizing its long-term administration. In such a way, more patients with mood disorders can become the beneficiaries of lithium's therapeutic action. KEY POINTS Lithium is a drug of choice as a mood-stabiliser for the maintenance treatment of bipolar disorder. Augmentation of antidepressants by lithium is one of the best strategies in treatment-resistant depression. Lithium exerts anti-suicidal, immunomodulatory, and neuroprotective action and may protect against dementia. Despite the evidence for the efficacy and added favourable properties, lithium is greatly underutilised in mood disorders. Challenging a scepticism about the use of lithium and optimising its long-term administration can make more patients with mood disorders the beneficiaries of lithium's therapeutic action.

Keywords: Lithium; bipolar disorder; herpes; mood-stabiliser; neuroprotection; suicide.

Publication types

  • Review

MeSH terms

  • Antimanic Agents / pharmacology*
  • Bipolar Disorder / drug therapy*
  • Dementia / prevention & control*
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Humans
  • Lithium Compounds / pharmacology*
  • Neuroprotective Agents / pharmacology*
  • Suicide Prevention*

Substances

  • Antimanic Agents
  • Lithium Compounds
  • Neuroprotective Agents